Kevin C. Gorman

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

NBIX

Current role

CEO, Board Member

2023-05-17–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	Neurocrine Biosciences Inc (NBIX)	Former Chief Executive Officer	$779,357	$1,141,950	$7,000,139	$6,999,698	—	$97,493	$16,018,637
2023	Neurocrine Biosciences Inc (NBIX)	Former Chief Executive Officer	$946,000	$1,040,600	$7,021,386	$6,678,790	—	$64,036	$15,750,812
2022	Neurocrine Biosciences Inc (NBIX)	Former Chief Executive Officer	$860,000	$989,000	$5,125,079	$4,875,106	—	$53,342	$11,902,527
2021	Neurocrine Biosciences Inc (NBIX)	Chief Executive Officer	$825,000	$701,250	$6,406,366	$6,093,752	—	$55,044	$14,081,412
2020	Neurocrine Biosciences Inc (NBIX)	Chief Executive Officer	$775,000	$542,500	$5,375,188	$7,124,633	—	$63,311	$13,880,632
2019	Neurocrine Biosciences Inc (NBIX)	Chief Executive Officer	$725,000	$667,000	$2,000,071	$6,000,525	—	$58,230	$9,450,826
2018	Neurocrine Biosciences Inc (NBIX)	Chief Executive Officer	$675,000	$425,250	$2,998,832	$4,486,852	—	$47,045	$8,632,979
2017	Neurocrine Biosciences Inc (NBIX)	Chief Executive Officer	$640,000	$515,200	$1,426,920	$4,929,898	—	$44,356	$7,556,374

No earnings-call appearances or filed executive changes recorded yet.